Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al

被引：8
作者：
Guilpain, Philippe [1 ,2 ]
Le Bihan, Clement [3 ]
Foulongne, Vincent [4 ]
Taourel, Patrice [5 ]
Pansu, Nathalie [3 ]
Maria, Alexandre Thibault Jacques [1 ,2 ]
Jung, Boris [6 ,7 ,8 ]
Larcher, Romaric [6 ,7 ,8 ]
Klouche, Kada [6 ,7 ,8 ]
Le Moing, Vincent [3 ]
机构：
[1] Univ Montpellier, Montpellier Univ Hosp, Local Referral Ctr Syst Autoimmune Dis, Internal Med Multiorgan Dis,Med Sch, Montpellier 5, France
[2] Univ Montpellier, IRMB, INSERM, Montpellier, France
[3] CHRU Montpellier, Hop St Eloi, Trop & Infect Dis, Montpellier 5, Herault, France
[4] Univ Montpellier I, INSERM, Pathogenesis & Control Chron Infect, Fac Med Montpellier Nimes, Montpellier, Languedoc Rouss, France
[5] Univ Hosp Ctr Montpellier, Osteoarticular Med Imaging Sect, Dept Med Imaging, Montpellier, Languedoc Rouss, France
[6] Univ Montpellier, Dept Intens Care Med, Lapeyronie Univ Hosp, INSERM,CNRS, Montpellier, France
[7] Univ Montpellier, PhyMedExp, CNRS, INSERM, Montpellier, France
[8] Univ Montpellier, CNRS, INSERM, Lapeyronie Univ Hosp, Montpellier, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷 / 03期
关键词：
D O I：
10.1136/annrheumdis-2020-217955
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 9 条
  • [1] Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab
    Avouac, Jerome
    Airo, Paolo
    Carlier, Nicolas
    Matucci-Cerinic, Marco
    Allanore, Yannick
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03)
  • [2] Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
    Grifoni, Alba
    Weiskopf, Daniela
    Ramirez, Sydney, I
    Mateus, Jose
    Dan, Jennifer M.
    Moderbacher, Carolyn Rydyznski
    Rawlings, Stephen A.
    Sutherland, Aaron
    Premkumar, Lakshmanane
    Jadi, Ramesh S.
    Marrama, Daniel
    de Silva, Aravinda M.
    Frazier, April
    Carlin, Aaron F.
    Greenbaum, Jason A.
    Peters, Bjoern
    Krammer, Florian
    Smith, Davey M.
    Crotty, Shane
    Sette, Alessandro
    [J]. CELL, 2020, 181 (07) : 1489 - +
  • [3] Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
    Guilpain, Philippe
    Le Bihan, Clement
    Foulongne, Vincent
    Taourel, Patrice
    Pansu, Nathalie
    Maria, Alexandre Thibault Jacques
    Jung, Boris
    Larcher, Romaric
    Klouche, Kada
    Le Moing, Vincent
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (01)
  • [4] Jordan RE, 2020, LANCET INFECT DIS
  • [5] Liu Q., 2020, CELL DISCOV, V6, P1, DOI [DOI 10.1038/S41421-020-0168-9, 10.1038/s41421-020-0168-9]
  • [6] Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
    Monti, Sara
    Balduzzi, Silvia
    Delvino, Paolo
    Bellis, Elisa
    Quadrelli, Verdiana Serena
    Montecucco, Carlomaurizio
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (05) : 667 - +
  • [7] VABRET N, 2020, IMMUNITY
  • [8] Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
    Yang, Xiaobo
    Yu, Yuan
    Xu, Jiqian
    Shu, Huaqing
    Xia, Jia'an
    Liu, Hong
    Wu, Yongran
    Zhang, Lu
    Yu, Zhui
    Fang, Minghao
    Yu, Ting
    Wang, Yaxin
    Pan, Shangwen
    Zou, Xiaojing
    Yuan, Shiying
    Shang, You
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (05) : 475 - 481
  • [9] Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
    Zhou, Fei
    Yu, Ting
    Du, Ronghui
    Fan, Guohui
    Liu, Ying
    Liu, Zhibo
    Xiang, Jie
    Wang, Yeming
    Song, Bin
    Gu, Xiaoying
    Guan, Lulu
    Wei, Yuan
    Li, Hui
    Wu, Xudong
    Xu, Jiuyang
    Tu, Shengjin
    Zhang, Yi
    Chen, Hua
    Cao, Bin
    [J]. LANCET, 2020, 395 (10229) : 1054 - 1062
1